Cannabis SIMPLY SOLVENTLESS ANNOUNCES CLOSING OF HIGHLY ACCRETIVE DELTA 9 BIO-TECH ACQUISITION, DELTA 9 BIO-TECH NAME CHANGE TO HUMBLE GROW CO., AND OFFICER APPOINTMENT March 2, 2025
Biotech POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS March 2, 2025
Food & Beverage Sucraid® (sacrosidase) Oral Solution. Free 4-Day Trial Now Available. The only FDA- approved therapy to treat CSID (Congenital Sucrase-Isomaltase Deficiency) March 2, 2025